@article{ref1,
title="Naltrexone in treatment of self injurious behavior: a clinical study",
journal="Research in developmental disabilities",
year="1987",
author="Szymanski, L. and Kedesdy, J. and Sulkes, S. and Cutler, A. and Stevens-Our, P.",
volume="8",
number="2",
pages="179-190",
abstract="It has been suggested that the parenteral opiate antagonist, naloxone, might ameliorate self-injurious behavior. However, clinical studies have had conflicting results. We have evaluated whether a potent oral opiate antagonist, naltrexone, is effective in the treatment of this condition. The study was conducted on two young, profoundly mentally retarded adults, who exhibited intractable self-injurious behavior. A double-blind, placebo-controlled, within-subject-withdrawal design was utilized. One subject was studied for 12 weeks and the other one for 18 weeks. No measurable effects on the self-injurious behavior were observed.<p /><p>Language: en</p>",
language="en",
issn="0891-4222",
doi="",
url="http://dx.doi.org/"
}